The gonadotrophins follicle stimulating hormone (FSH) and luteinizing hormone (LH) are key hormones in the regulation of ovarian function. In the present study, the expression of LH/human chorionic gonadotrophin (HCG) receptor mRNAs in the human ovary was examined. Northern blot analysis was used to measure relative amounts of LH/HCG receptor mRNA, and in-situ hybridization was used to localize LH/HCG receptor transcripts. Northern blot analysis of human ovaries detected three transcripts (5.4, 3.6 and 2.4 kb) for the LH/HCG receptor. LH/HCG receptor mRNA concentrations increased from preovulatory follicles to the corpus luteum of the midluteal phase, and decreased at the late luteal phase. Using in-situ hybridization, LH/HCG receptor mRNA was located predominantly in granulosa cells in the same follicle. Cloning of the human LH/ HCG receptor cDNA previously revealed the existence of two alternative forms of the receptor differing by the presence (HLH-Ra) and absence (HLH-Rb) of 62 amino acids encoded by exon 9. We have studied the functional significance of these receptor isoforms and have confirmed that they are generated by alternative splicing. A reverse transcription-polymerase chain reaction amplification was used to detect different isoforms of LH receptor mRNAs in ovary and placenta. The expression of the two mRNA forms of LH/HCG receptor were detected in ovary, and at very low concentrations in placenta. Treatment with HCG caused a dosedependent increase in cAMP production with an initial response evident at~1 ng/ml HCG in COS-7 cells expressing HLH-Ra. However, a complete loss of signal transduction was found in cells transfected with the truncated HLH-Rb.
Introduction
of their respective ligands. HCG binds with high affinity to the extracellular domain of the LH/HCG receptor (Xie et al., The gonadotrophins follicle stimulating hormone (FSH) and 1990; Braun et al., 1991) . Binding to the LH/HCG receptor luteinizing hormone (LH) are produced by the pituitary gland, leads to activation of adenylyl cyclase, with a subsequent and are essential for normal sexual development and reproductincrease in cAMP levels, presumably via coupling to G ive function. Although the importance of gonadotrophins in proteins. The cloning of the human LH/HCG receptor cDNA gonadal development and reproductive function has been indicated two forms of receptor which differ by the presence established, progress toward elucidation of the structure of the or absence of 62 amino acids near the carboxyl terminus of human gonadotrophin receptors has been hampered by the the receptor extracellular regions (Minegishi et al., 1990) . This small quantity of these receptors and the limited availability 62 amino acid insert is encoded by a discrete exon 9 (Koo of human tissue. Substantial progress has recently been made et al., 1991; Tsai Morris et al., 1991; Atger et al., 1995) , and in elucidating the structure of the gonadotrophin receptors the two LH/HCG receptor mRNA transcripts result from (Loosfelt et al., 1989; MacFarland et al., 1989) . The human alternative splicing of exon 9 and are expressed in the human LH/human chorionic gonadotrophin (HCG) receptor has been ovary. To study the regulation of the LH/HCG receptor in the cloned, and belongs to a large family of G protein-coupled human ovary and placenta we have identified these splice receptors (Minegishi et al., 1990; Tilly et al., 1992) . To date, variants by reverse transcription-polymerase chain reaction little is known about changes in LH/HCG receptor mRNA in (RT-PCR). To investigate the biological significance of this the human ovary during the menstrual cycle. In this paper, we observation, COS-7 cells were transfected with an expression have examined the expression of LH/HCG receptor mRNAs vector encoding for the full-length and short form LH/HCG in follicles and corpora lutea in a normal menstrual cycle, and receptor cDNA. have determined the cellular distribution of receptor transcripts
The physiological significance of the regulation of the using in-situ hybridization.
splicing event is unknown, but we report here that a fundaThe large extracellular domain of these receptors appears to be responsible for the recognition and high affinity binding mental property of the receptor, cAMP production, is affected by splicing. The alternative splicing mechanisms that give rise to the receptor variants may be subject to metabolic regulation or altered in pathophysiological states, leading to modulation of tissue expression of the receptor variants and resulting in potential changes in LH action.
Materials and methods

Hormones and reagents
Highly purified HCG (CR 127) was obtained from the National Hormone and Pituitary Program (NIDDK, Baltimore, MD, USA). Anti-cAMP serum was donated by Dr K.Wakabayashi (Biosignal Research Center Institute for Molecular and Cellular Regulation, Gunma University, Japan).
Tissue preparation
Human ovaries were removed from patients who had undergone salpingoophorectomy for gynaecological diseases. Pathological examination of the ovaries revealed no apparent abnormalities, and none of the patients had received hormone treatment for 6 months prior to surgery. Placental tissues were collected from therapeutic abortion (8 weeks of pregnancy and 18 weeks of pregnancy) and from elective Caesarean section because of cephalopelvic disproportion (38 weeks of pregnancy). Informed consent was obtained from all human subjects, and this study was approved by the Gunma University School Institutional Review Board. The menstrual history, basal body temperature record and/or endometrial histology of the patient were used to determine the date of menstrual cycle and the week of pregnancy.
Northern blot analysis
After whole ovaries were removed, leading follicles (14 day follicle) and corpora lutea (21 day and 30 day corpus luteum), with day 1 being the first day of the last menstrual period, were isolated and Figure 1 . (A) Northern blot analysis of luteinizing hormone/human stored in liquid nitrogen until use. Total RNA was extracted from chorionic gonadotrophin (LH/HCG) receptor mRNA in human human ovaries by the guanidium thiocyanate method (Chomczynski ovary. Total RNA (15 µg) samples were prepared from the ovary (1 ϭ 14 day follicle; 2 ϭ 21 day corpus luteum; 3 ϭ 30 day and Sacchi, 1987) . The final RNA pellet was dissolved in diethyl corpus luteum), and were fractionated by electrophoresis through a pyrocarbonate-treated H 2 O and total RNA was quantified by measur-1% agarose gel. The samples were blotted onto nitrocellulose ing the absorbance of samples at 260 nm. For Northern blot analysis, membranes and covalently cross-linked with a UV cross-linker 15 µg total RNA from each tissue was separated by electrophoresis (Stratagene). Migration distances of the 28S and 18S ribosomal on denaturing 1% agarose gels and subsequently transferred to a RNAs of a parallel total RNA sample are indicated. Filters were nylon membrane (Biodyne, ICN, Glen Cove, NY, USA). The samples hybridized with the LH/HCG receptor and β-actin cRNA probes as were covalently cross-linked with a UV cross-linker (Stratagene, La described in the Materials and methods section. Samples are (a) 4 h Jolla, CA, USA). Northern blots were hybridized at 68°C with and (b) 1 h exposures of the different blots. This Northern blot is digoxigenin-labelled cRNA probes for the LH/HCG receptor and β-representative of four experiments. (B) Luminescence detection of LH/HCG receptor (2.4 kb) was quantified by densitometric actin. Under the standard protocol for the nucleic acid detection kit scanning. Data were normalized for the amount of β-actin mRNA used (Boehringer Mannheim, Indianapolis, IN, USA), membranes in each sample and expressed relative to the value of 14 day were then exposed to Kodak X-Omat film (Eastman Kodak, Rochester, follicles. Each point represents the average Ϯ SE of four different NY, USA). Human LH/HCG receptor cDNA (Minegishi et al., 1990) determinations (1 ϭ 14 day follicle; 2 ϭ 21 day corpus luteum; were subcloned into the EcoR1 site of the Bluescript KS (ϩ) vector 3 ϭ 30 day corpus luteum). and linearized with Bam H1 for LH/HCG receptor. Digoxigeninlabelled LH/HCG receptor cRNA probe was produced by in-vitro
In-situ hybridization transcription with T7 RNA polymerase and an RNA labelling kit (Boehringer Mannheim). A digoxigenin-labelled β-actin cRNA probe Human ovaries were embedded in tissue compound and frozen in was obtained by the same method. The relative abundance of a 5.4 liquid nitrogen. Sections (7 µm thick) were cut by a cryostat and kb signal for LH/HCG receptor in the different preparations was mounted on silane-coated glass slides for in-situ hybridization. The quantified with an LKB 2202 UnitroScan Laser Densitometer (LKB tissue sections were fixed in 4% paraformaldehyde in phosphateProdukter AB, Bromma, Sweden) and normalized against amounts buffered saline (PBS) and then hybridized with digoxigenin-labelled of β-actin mRNA in each sample and expressed relative to the control riboprobe in hybridization buffer (1 mg/ml yeast tRNA, 20 mM TrisHCl, 2.5 mM EDTA, pH 8.0, 1ϫ Denhard's solution, 0.3 M NaCl, value (100%). medium (DMEM) containing 10% fetal calf serum] in a humidified atmosphere containing 5% CO 2 and used for transfection of receptor cDNAs. Transient transfections using the calcium phosphate method were initiated when the cells were 50-70% confluent.
Measurement of cAMP
To investigate hormone-mediated cAMP production, exponentially growing COS-7 cells were transfected with recombinant expression vectors. At 48 h after transfection, cells were washed twice in PBS and incubated with DMEM containing 1 mg/ml bovine serum albumin (BSA) and 0.5 mM 3-isobutyl-1-methylxanthine (MIX). The cells were then incubated for 30 min at 37°C in the same medium containing varying concentrations of HCG. The cells were then rinsed twice with PBS at 4°C and lysed with 1 ml 95% ethanol (Hirayu et al., 1985) . The cellular debris was removed by centrifugation and the supernatants were lyophilized. The resulting freeze-dried pellets were resuspended in 0.3 M imidazole buffer and the cAMP in each sample was quantified using an radioimmunoassay method (Hattori et al., 1985) . Triplicate plates were analysed for each data point.
RT-PCR analysis
For PCR amplification, 3 µg of poly(A)ϩ RNA was used to generate first strand cDNA using a cDNA synthesis kit (BRL, Grand Island, NY, USA), following the manufacturer's instructions. The entire 2 µl cDNA synthesis reaction volume was combined in a 100 µl final reaction volume for PCR amplification containing 0.25 µM of each oligonucleotide primer and 1.5 IU Taq DNA polymerase (Perkin Elmer Cetus, Fofter, CA, USA). The primer sequences were: 5Ј-TTCGGATCC-TACATCTGGAGAAGATGCACAATG (LHR-S1) 5Ј-TCGAGAATTC-AGGTGAATAGCATAGGTGATGGTG (LHR-AS2)
In all, 30 cycles of PCR amplification were performed using a DNA thermal cycler (Perkin Elmer Cetus). Each cycle consisted of Figure 2 . In-situ hybridization of the human ovary with 90 s denaturation at 95°C, 150 s annealing at 62°C, and 150 s at digoxigenin-labelled riboprobe for human luteinizing hormone/ 70°C for enzymatic extension. After DNA amplification the PCR human chorionic gonadotrophin (LH/HCG) receptors. The tissue mixture was extracted with phenol-chloroform followed by ethanol sections were fixed with 4% paraformaldehyde in phosphateprecipitation. LH/HCG receptor PCR-product DNA was then elecbuffered saline (PBS) and then hybridized with (a) digoxigeninlabelled antisense LH/HCG receptor and (b) sense LH/HCG RNA trophoresed on 2% agarose gels. In one experiment the PCR-product probes in the hybridization buffer. Hybridized sections were then DNA of LH/HCG receptor was digested with the restriction enzyme washed as described in the Materials and methods section. A HincII before gel electrophoresis and visualized after ethidium bromspecific hybridization signal is seen in the granulosa cells of the ide staining by UV fluorescence. PCR product gels were Southern follicles (a), but was absent in (b). G ϭ granulosa cell expression; blotted using standard methods. After alkaline denaturation and Th ϭ thecal cell expression. Original magnification ϫ100.
neutralization, gels were transferred to a nylon membrane filter. After fixation by UV irradiation, the filter was hybridized with 32 P-labelled 50% deionized formamide, 10% dextran sulphate) for 16 h at 50°C.
cDNA. The LH/HCG receptor cDNA was labelled with 32 P by Hybridized sections were then washed with 2ϫ sodium chloride/ random priming and used to hybridize with DNA blots with stringent sodium citrate (SSC)/50% formamide after treatment with RNase A hybridization (42°C, 50% formamide) and washing (20 µg/ml in 10 mM Tris-HCl, pH 7.6, 500 mM NaCl, 1 mM EDTA) (0.25 ϫ SCC, 68°C) conditions followed by luminescence detection. for 30 min at 37°C. The hybridization material was reacted with alkaline phosphatase-conjugated anti-digoxigenin antibody and then Subcloning and sequencing of PCR products detected by colour reaction in the incubation medium containing Amplified DNA fragments were recovered from agarose gels by Nitroblue tetrazolium, 5-bromo-4-chloro-3-indolyl-phosphate and levGeneclean II (Bio 101, Vista, CA, USA), precipitated with ethanol, amisole, an inhibitor of endogenous alkaline phosphatase, according digested with Bam Hl (site in primer A) and EcoRI (site in primer to the manufacturer's manual (Digoxigenin Detection kit; Boehringer B) before subcloning into M13 (mp 18 and mp 19). Single-stranded Mannheim).
phage DNA was sequenced by the dideoxy-chain termination method.
Construction of expression vector encoding HLH-R
The HLH-Ra (human LH/HCG receptor full-length) and HLH-Rb
Results
(short form) were isolated from a corpus luteum cDNA library as
Northern blot analysis of human ovary mRNA indicated three of LH/HCG receptor mRNA increased from preovulatory (8, 18 and 38 weeks) of pregnancy. No attempts were made in the present study to quantify the reverse transcription and follicles to the corpus luteum of midluteal phase and subsequently decreased at the late luteal phase.
PCR products. COS-7 cells were transiently transfected with an expression In-situ hybridization of human ovarian sections was performed using LH/HCG antisense and sense RNA probes vector containing the full-length cDNA (HLH-Ra) or a truncated cDNA (HLH-Rb) of the human luteal LH/HCG (Figure 2 ). LH/HCG receptor gene expression appears to be localized to the granulosa cells of the follicle. No specific receptor. Transfection of COS-7 cell with cDNA expression plasmids for either form of the LH/HCG receptor were hybridization was observed when sense LH/HCG receptor RNA probes were used.
confirmed by RT-PCR using the primers (LHR-S1 and LHR-AS2). LH/HCG receptors were characterized for bioloWe have demonstrated the existence of two alternative forms of the human LH/HCG receptor which differ according to the gical activity (transduction of the hormonal signal), as measured by an increase in intracellular cAMP. COS cells transfected presence or absence of 62 amino acids near the C-terminus of the extracellular domain of the receptor (Figure 3) . The with the full-length DNA expressed HLH-Ra which responded to HCG stimulation with a dose-dependent increase in cAMP genomic sequence data of the rat and human LH/HCG receptor revealed that the 186 nucleotides were encoded by exon 9 of production, the initial response being~1 ng/ml HCG. The basal values of cAMP production in cells after transfection the LH/HCG receptor gene. LH/HCG receptor mRNA in the human corpus luteum may therefore consist of two transcripts with LH-Ra and LH-Rb were 0.5-1.0 pmole/1.5ϫ10 5 cells. In a control mock transfection in two experiments, cAMP generated by alternative mRNA splicing. Two oligonucleotide primers (LHR-S1 and LHR-AS2) were used to amplify LH/ production induced by HCG was similar to the basal values of LH-Ra cells. A complete loss of signal transduction was HCG receptor cDNA by PCR. The predicted size of the fragments was 817 and/or 631 bp (Figure 4a ). The PCR found in cells transfected with truncated receptor (Figure 5 ). products were transferred to nylon membranes and subjected to Southern hybridization with LH/HCG receptor cDNA. As
Discussion
shown in the example presented in Figure 4 , PCR with this primer set resulted in two specific bands corresponding to the Previous studies have demonstrated the expression of LH/ HCG receptor mRNA in human ovary (Igarashi et al., 1994; presence (817 bp) and absence (631 bp) of exon 9.
To verify that the larger cDNA contained exon 9, a restriction Nishimori et al., 1995) . Northern blot analysis revealed the presence of multiple LH/HCG receptor mRNA transcripts digest with HincII, specific to the larger cDNA, was performed (Figure 4b ). Subcloning and dideoxy sequencing of both the in the human ovary during the menstrual cycle. We have demonstrated that the amounts of LH/HCG receptor mRNA 817 and 631 bp cDNAs revealed the normal receptor sequence in this region with or without exon 9 respectively. The amounts increased from the follicular phase to the luteal phase and subsequently decreased during the late luteal phase. LH is the of the two species of cDNA were equivalent when amplified from RNA obtained from the ovary at various phases of major physiological luteotrophic factor for the human corpus luteum, regulating its life span and function, and is released menstruation. A very small amount of expression of LH/HCG receptor mRNA was found in placenta from the different term from the pituitary at the midfollicular phase. These data cells of nearly all the follicles had receptors for FSH, but that only those present in large preovulatory follicles had receptors for LH. Thus, species differences may exist between nonhuman primates and humans in the regulation of LH/HCG in monkey corpora lutea (Ravindranath et al., 1992) , suggesting that the expression of the LH/HCG receptor might be regulated by post-transcriptional control mechanisms. Our present studies indicate that the expression of LH/HCG receptor changes as a function of luteal age. On the other hand, Duncan et al. suggest that the alternative splicing pattern of LH/HCG receptor mRNA may also have an important role in the regulation of (1996) studied the expression of the LH/HCG receptors in human corpora lutea throughout the functional luteal phase the formation of functional LH receptors. Molecular cloning of the LH/HCG receptor has indicated and after 'rescue' with exogenous HCG. They reported that LH/HCG receptor mRNA increased in the early luteal phase the existence of several variant forms of LH/HCG receptor mRNA, with a complex pattern of transcripts detected by RNA and was continually expressed in the corpus luteum throughout the luteal phase. As the definition of the late luteal phase hybridization (Loosfelt et al., 1989; Bernard et al., 1990; Minegishi et al., 1990) . Variant forms of the LH/HCG receptor differs in each study, it may be possible that the corpora lutea used in our experiment were closer to the completion of have been detected in porcine (Loosfelt et al., 1989) and rat species (Bernard et al., 1990; Tsai Moris et al., 1990 ; Wang functional luteolysis than those used by Duncan et al. (1996) . LH/HCG receptor mRNA was demonstrated in human et al., 1991a). They lack the transmembrane domain and/or the intracellular domain of the receptor and are generated by follicles during the follicular phase by in-situ hybridization. These findings corroborate the results of Northern analysis of an alternative splicing mechanism. No such variants have been reported to date in the human. LH/HCG receptor mRNA expression.
Previous studies in rat ovary suggested that the granulosa We have demonstrated that two isoforms of the human LH/
